Sequenom (SQNM) says it's achieved positive results from a study of its RetnaGene AMD...
Sequenom (SQNM) says it's achieved positive results from a study of its RetnaGene AMD laboratory-developed test, which is designed to accurately predict the risk of disease progression of age-related macular degeneration. The announcement was made during its presentation today at the 2012 Joint Meeting of the American Academy of Ophthalmology and the Asia-Pacific Academy of Ophthalmology in Chicago. Shares +0.3% AH.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Feb 26, 2015)
at Benzinga.com (Jan 13, 2015)
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs